| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.02B | 54.41B | 53.42B | 48.52B | 42.34B | 35.59B |
| Gross Profit | 25.43B | 26.08B | 24.48B | 21.34B | 18.23B | 14.93B |
| EBITDA | 8.31B | 8.39B | 8.43B | 7.91B | 6.54B | 5.08B |
| Net Income | 4.12B | 4.28B | 4.93B | 4.38B | 3.54B | 2.62B |
Balance Sheet | ||||||
| Total Assets | 67.14B | 69.96B | 66.14B | 60.14B | 55.82B | 49.46B |
| Cash, Cash Equivalents and Short-Term Investments | 18.84B | 21.34B | 16.93B | 14.51B | 14.32B | 13.20B |
| Total Debt | 2.78B | 2.87B | 3.07B | 2.67B | 2.42B | 2.47B |
| Total Liabilities | 15.13B | 16.40B | 16.07B | 14.88B | 15.61B | 13.32B |
| Stockholders Equity | 45.95B | 46.85B | 44.16B | 40.03B | 35.62B | 32.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.08B | 4.95B | 2.48B | 3.02B | 4.09B |
| Operating Cash Flow | 0.00 | 9.75B | 6.77B | 4.33B | 3.89B | 4.60B |
| Investing Cash Flow | 0.00 | -3.25B | -1.26B | -3.32B | -1.08B | -1.07B |
| Financing Cash Flow | 0.00 | -3.93B | -3.58B | -2.36B | -2.10B | -1.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥72.42B | 9.50 | ― | 2.63% | -3.87% | -17.81% | |
76 Outperform | ¥58.73B | 10.64 | ― | 2.79% | 3.18% | -4.06% | |
75 Outperform | ¥63.32B | 13.24 | ― | 3.95% | -0.98% | -15.59% | |
72 Outperform | ¥40.21B | 12.91 | ― | 3.95% | 0.32% | 75.60% | |
70 Outperform | ¥160.81B | 7.70 | 8.17% | 2.04% | 1.06% | 72.65% | |
70 Outperform | ¥82.39B | 4.09 | ― | 3.09% | 10.53% | -25.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |